Search results
Results from the WOW.Com Content Network
Lisinopril is a medication belonging to the drug class of angiotensin-converting enzyme (ACE) inhibitors and is used to treat hypertension (high blood pressure), heart failure, and heart attacks. [7] For high blood pressure it is usually a first-line treatment. It is also used to prevent kidney problems in people with diabetes mellitus. [7]
Drug dosages from Drug Lookup, Epocrates Online. Name Equivalent daily dose Start Usual Maximum Benazepril: 10 mg: 10 mg: 20–40 mg: 80 mg Captopril: 50 mg (25 mg bid) 12.5–25 mg bid-tid: 25–50 mg bid-tid: 150 mg/d Enalapril: 5 mg: 5 mg: 10–40 mg: 40 mg Fosinopril: 10 mg: 10 mg: 20–40 mg: 80 mg Lisinopril: 10 mg: 10 mg: 10–40 mg: 80 ...
Lisinopril/amlodipine, sold under the brand name Lisonorm among others, is a medication used to treat high blood pressure. [1] It is a combination of lisinopril, an ACE inhibitor,with amlodipine, a calcium channel blocker. [1] It may be used when blood pressure is not well controlled with each of the two agents alone. [4] It is taken by mouth. [1]
"If you are 18 hours late, skip it and take the normal scheduled dose at the next scheduled time." It's generally best not to try to compensate by taking more medication than normal the following day.
Dosage typically includes information on the number of doses, intervals between administrations, and the overall treatment period. [3] For example, a dosage might be described as "200 mg twice daily for two weeks," where 200 mg represents the individual dose, twice daily indicates the frequency, and two weeks specifies the duration of treatment.
An equianalgesic chart is a conversion chart that lists equivalent doses of analgesics (drugs used to relieve pain). Equianalgesic charts are used for calculation of an equivalent dose (a dose which would offer an equal amount of analgesia) between different analgesics. [1]
Valsartan, sold under the brand name Diovan among others, is a medication used to treat high blood pressure, heart failure, and diabetic kidney disease. [8] It belongs to a class of medications referred to as angiotensin II receptor blockers (ARBs).
The cost of PR and other marketing, about 12 cents per dose, was about twice the cost of the actual drug, according to other internal J&J budget analyses. Profit for Johnson & Johnson ($1.050 billion in revenue against $103 million in costs) was projected at about $950 million.